Arovella Therapeutics LimitedASX: ALA

Strong Revenue Growth for SUDA Subsidiary

Jul 24, 2017 at 2:45 AM UTC · Issued by Arovella Therapeutics Limited

Arovella Therapeutics Ltd has released a press release.

View Attachment